Cell defense systems against oxidative stress and endoplasmic reticulum stress: Mechanisms of regulation and the effect of hepatitis C virus

Molecular Biology

Volumn 45, Issue 1, 2011, Pages 110-122

  Smirnova, O A ^a   Ivanov, A V ^a   Ivanova, O N ^a   Valuev Elliston, V T ^a   Kochetkov, S N ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

endoplasmic reticulum stress; hepatitis C virus; oxidative stress; regulation; transcription factor

Indexed keywords

HEPATITIS C VIRUS;

EID: 79951977937     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893311010122     Document Type: Review

References (139)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. 1999. J. Viral. Hepat. 6, 35-47.
2. Martell M., Esteban J. I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., Gomez J. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J. Virol. 66, 3225-3229.
3. Bostan N., Mahmood T. 2010. An overview about hepatitis C: A devastating virus. Crit. Rev. Microbiol. 36, 91-133.
4. Lemon S. A., Walker C. M., Alter M. J., Yi M.-K. 2007. Hepatitis C virus. In: Fields Virology, vol. 1. Eds. Knipe D. M., Howley P. M. Philadelphia, PA.: Lippincott Williams & Wilkins, pp. 1253-1304.
5. Rosen H. R., Gretch D. R. 1999. Hepatitis C virus: Current understanding and prospects for future therapies. Mol. Med. Today. 5, 393-399.
6. Nocente R., Ceccanti M., Bertazzoni G., Cammarota G., Silveri N. G., Gasbarrini G. 2003. HCV infection and extrahepatic manifestations. Hepatogastroenterology. 50, 1149-1154.
7. Fried M. W., Shiffman M. L., Reddy K. R., Smith C., Marinos G., Goncales F. L., Jr., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347, 975-982.
8. Manns M. P., Wedemeyer H., Cornberg M. 2006. Treating viral hepatitis C: Efficacy, side effects, and complications. Gut. 55, 1350-1359.
9. Ronn R., Sandstrom A. 2008. New developments in the discovery of agents to treat hepatitis C. Curr. Top. Med. Chem. 8, 533-562.
10. McHutchison J. G., Everson G. T., Gordon S. C., Jacobson I. M., Sulkowski M., Kauffman R., McNair L., Alam J., Muir A. J. 2009. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N. Engl. J. Med. 360, 1827-1838.
11. Tillmann H. L., Manns M. P., Rudolph K. L. 2005. Merging models of hepatitis C virus pathogenesis. Semin. Liver Dis. 25, 84-92.
12. Smirnova I. S., Aksenov N. D., Vonsky M. S., Isaguliants M. G. 2006. Different transformation pathways of murine fibroblast NIH 3T3 cells by hepatitis C virus core and NS3 proteins. Cell Biol. Int. 30, 915-919.
13. Park J. S., Yang J. M., Min M. K. 2000. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem. Biophys. Res. Commun. 267, 581-587.
14. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., Koike K. 2001. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 61, 4365-4370.
15. Tardif K. D., Mori K., Siddiqui A. 2002. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J. Virol. 76, 7453-7459.
16. Oh J. W., Sheu G. T., Lai M. M. 2000. Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J. Biol. Chem. 275, 17710-17717.
17. Xu Z., Choi J., Yen T. S., Lu W., Strohecker A., Govindarajan S., Chien D., Selby M. J., Ou J. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20, 3840-3848.
18. Acosta-Rivero N., Rodriguez A., Musacchio A., Falcon V., Suarez V. M., Chavez L., Morales-Grillo J., Duenas-Carrera S. 2004. Nucleic acid binding properties and intermediates of HCV core protein multimerization in Pichia pastoris. Biochem. Biophys. Res. Commun. 323, 926-931.
19. Tanaka Y., Shimoike T., Ishii K., Suzuki R., Suzuki T., Ushijima H., Matsuura Y., Miyamura T. 2000. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5′ untranslated region of the viral genome. Virology. 270, 229-236.
20. Kao C. F., Chen S. Y., Chen J. Y., Wu Lee Y. H. 2004. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene. 23, 2472-2483.
21. Mamiya N., Worman H. J. 1999. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 274, 15751-15756.
22. Dansako H., Naganuma A., Nakamura T., Ikeda F., Nozaki A., Kato N. 2003. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res. 97, 17-30.
23. Korenaga M., Wang T., Li Y., Showalter L. A., Chan T., Sun J., Weinman S. A. 2005. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem. 280, 37481-37488.
24. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y. S., Rice C. M., Dubuisson J. 1997. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71, 697-704.
25. Lavillette D., Pecheur E. I., Donot P., Fresquet J., Molle J., Corbau R., Dreux M., Penin F., Cosset F. L. 2007. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81, 8752-8765.
26. Ciccaglione A. R., Marcantonio C., Tritarelli E., Equestre M., Magurano F., Costantino A., Nicoletti L., Rapicetta M. 2004. The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death. Virus Res. 104, 1-9.
27. Chan S. W., Egan P. A. 2005. Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response. FASEB J. 19, 1510-1512.
28. Griffin S. D., Beales L. P., Clarke D. S., Worsfold O., Evans S. D., Jaeger J., Harris M. P., Rowlands D. J. 2003. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 535, 34-38.
29. Steinmann E., Penin F., Kallis S., Patel A. H., Bartenschlager R., Pietschmann T. 2007. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog. 3, e103.
30. Tai C. L., Chi W. K., Chen D. S., Hwang L. H. 1996. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol. 70, 8477-8484.
31. Sali D. L., Ingram R., Wendel M., Gupta D., McNemar C., Tsarbopoulos A., Chen J. W., Hong Z., Chase R., Risano C., Zhang R., Yao N., Kwong A. D., Ramanathan L., Le H. V., Weber P. C. 1998. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Biochemistry. 37, 3392-3401.
32. Lundin M., Monne M., Widell A., Von Heijne G., Persson M. A. 2003. Topology of the membrane-associated hepatitis C virus protein NS4B. J. Virol. 77, 5428-5438.
33. Zheng Y., Gao B., Ye L., Kong L., Jing W., Yang X., Wu Z. 2005. Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response. J. Microbiol. 43, 529-536.
34. Macdonald A., Harris M. 2004. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85, 2485-2502.
35. Tellinghuisen T. L., Marcotrigiano J., Gorbalenya A. E., Rice C. M. 2004. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J. Biol. Chem. 279, 48576-48587.
36. Waris G., Sarker S., Siddiqui A. 2004. Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA. 10, 321-329.
37. Arima N., Kao C. Y., Licht T., Padmanabhan R., Sasaguri Y., Padmanabhan R. 2001. Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J. Biol. Chem. 276, 12675-12684.
38. Gong G., Waris G., Tanveer R., Siddiqui A. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. U. S. A. 98, 9599-5604.
39. Francois C., Duverlie G., Rebouillat D., Khorsi H., Castelain S., Blum H. E., Gatignol A., Wychowski C., Moradpour D., Meurs E. F. 2000. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74, 5587-5596.
40. Lohmann V., Korner F., Herian U., Bartenschlager R. 1997. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71, 8416-8428.
41. Uchida M., Hino N., Yamanaka T., Fukushima H., Imanishi T., Uchiyama Y., Kodama T., Doi T. 2002. Hepatitis C virus core protein binds to a C-terminal region of NS5B RNA polymerase. Hepatol. Res. 22, 297-306.
42. Berger K. L., Randall G. 2009. Potential roles for cellular cofactors in hepatitis C virus replication complex formation. Commun. Integr. Biol. 2, 471-473.
43. Piccininni S., Varaklioti A., Nardelli M., Dave B., Raney K. D., McCarthy J. E. 2002. Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein. J. Biol. Chem. 277, 45670-45679.
44. Ivanov A. V., Tunitskaya V. L., Ivanova O. N., Mitkevich V. A., Prassolov V. S., Makarov A. A., Kukhanova M. K., Kochetkov S. N. 2009. Hepatitis C virus NS5A protein modulates template selection by the RNA polymerase in in vitro system. FEBS Lett. 583, 277-280.
45. Koike K., Moriya K., Matsuura Y. 2010. Animal models for hepatitis C and related liver disease. Hepatol. Res. 40, 69-82.
46. Mercer D. F., Schiller D. E., Elliott J. F., Douglas D. N., Hao C., Rinfret A., Addison W. R., Fischer K. P., Churchill T. A., Lakey J. R., Tyrrell D. L., Kneteman N. M. 2001. Hepatitis C virus replication in mice with chimeric human livers. Nature Med. 7, 927-933.
47. Barth H., Robinet E., Liang T. J., Baumert T. F. 2008. Mouse models for the study of HCV infection and virus-host interactions. J. Hepatol. 49, 134-142.
48. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244, 359-362.
49. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 285, 110-113.
50. Blight K. J., McKeating J. A., Marcotrigiano J., Rice C. M. 2003. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J. Virol. 77, 3181-3190.
51. Bartenschlager R., Kaul A., Sparacio S. 2003. Replication of the hepatitis C virus in cell culture. Antiviral Res. 60, 91-102.
52. Lindenbach B. D., Evans M. J., Syder A. J., Wolk B., Tellinghuisen T. L., Liu C. C., Maruyama T., Hynes R. O., Burton D. R., McKeating J. A., Rice C. M. 2005. Complete replication of hepatitis C virus in cell culture. Science. 309, 623-626.
53. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H. G., Mizokami M., Bartenschlager R., Liang T. J. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Med. 11, 791-796.
54. Kato T., Furusaka A., Miyamoto M., Date T., Yasui K., Hiramoto J., Nagayama K., Tanaka T., Wakita T. 2001. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64, 334-339.
55. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology. 125, 1808-1817.
56. Salganik R. I. 2001. The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population. J. Am. Coll. Nutr. 20, 464S-472S.
57. Chernyak B. V., Izyumov D. S., Lyamzaev K. G., Pashkovskaya A. A., Pletjushkina O. Y., Antonenko Y. N., Sakharov D. V., Wirtz K. W., Skulachev V. P. 2006. Production of reactive oxygen species in mitochondria of HeLa cells under oxidative stress. Biochim. Biophys. Acta. 1757, 525-534.
58. Papa S., Skulachev V. P. 1997. Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell. Biochem. 174, 305-319.
59. Lee J. M., Johnson J. A. 2004. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J. Biochem. Mol. Biol. 37, 139-143.
60. Aleksunes L. M., Manautou J. E. 2007. Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol. Pathol. 35, 459-473.
61. Nguyen T., Huang H. C., Pickett C. B. 2000. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275, 15466-15473.
62. Zhang Y., Lucocq J. M., Yamamoto M., Hayes J. D. 2007. The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation. Biochem. J. 408, 161-172.
63. Wang W., Chan J. Y. 2006. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J. Biol. Chem. 281, 19676-19687.
64. Zhang Y., Lucocq J. M., Hayes J. D. 2009. The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors. Biochem. J. 418, 293-310.
65. Villeneuve N. F., Lau A., Zhang D. D. 2010. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: An insight into cullin-ring ubiquitin ligases. Antioxid. Redox Signal. doi: 10. 1089/ars. 2010. 3211.
66. Ohtsuji M., Katsuoka F., Kobayashi A., Aburatani H., Hayes J. D., Yamamoto M. 2008. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J. Biol. Chem. 283, 33554-33562.
67. Chan J. Y., Kwong M., Lu R., Chang J., Wang B., Yen T. S., Kan Y. W. 1998. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 17, 1779-1787.
68. Beyer T. A., Xu W., Teupser D., auf dem Keller U., Bugnon P., Hildt E., Thiery J., Kan Y. W., Werner S. 2008. Impaired liver regeneration in Nrf2 knockout mice: Role of ROS-mediated insulin/IGF-1 resistance. EMBO J. 27, 212-223.
69. Dhakshinamoorthy S., Jaiswal A. K. 2000. Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H: Quinone oxidoreductase1 gene. J. Biol. Chem. 275, 40134-40141.
70. Motohashi H., Katsuoka F., Engel J. D., Yamamoto M. 2004. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. U. S. A. 101, 6379-6384.
71. Levonen A. L., Landar A., Ramachandran A., Ceaser E. K., Dickinson D. A., Zanoni G., Morrow J. D., Darley-Usmar V. M. 2004. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378, 373-382.
72. Jaiswal A. K. 2004. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36, 1199-1207.
73. Sun Z., Chin Y. E., Zhang D. D. 2009. Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol. Cell Biol. 29, 2658-2672.
74. Menshikova E. B., Tkachev V. O., Zenkov N. K. 2010. Redox-dependent signaling system Nrf2/ARE in inflammation. Mol. Biol. (Moscow). 44, 343-357.
75. Reddy P. S., Corley R. B. 1998. Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. BioEssays. 20, 546-554.
76. Malhotra J. D., Kaufman R. J. 2007. Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword? Antioxid. Redox Signal. 9, 2277-2293.
77. Boelens J., Lust S., Offner F., Bracke M. E., Vanhoecke B. W. 2007. Review. The endoplasmic reticulum: A target for new anticancer drugs. In Vivo. 21, 215-226.
78. Zhang K., Kaufman R. J. 2003. Unfolding the toxicity of cholesterol. Nature Cell Biol. 5, 769-770.
79. Ma Y., Hendershot L. M. 2001. The unfolding tale of the unfolded protein response. Cell. 107, 827-830.
80. Shiu R. P., Pouyssegur J., Pastan I. 1977. Glucose depletion accounts for the induction of two transformation-sensitive membrane proteins in Rous sarcoma virus-transformed chick embryo fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 74, 3840-3844.
81. Gething M. J., Sambrook J. 1992. Protein folding in the cell. Nature. 355, 33-45.
82. Schroder M., Kaufman R. J. 2005. ER stress and the unfolded protein response. Mutat. Res. 569, 29-63.
83. Pahl H. L., Sester M., Burgert H. G., Baeuerle P. A. 1996. Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention. J. Cell Biol. 132, 511-522.
84. Pahl H. L., Baeuerle P. A. 1995. A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J. 14, 2580-2588.
85. Martinon F., Chen X., Lee A. H., Glimcher L. H. 2010. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nature Immunol. 11, 411-418.
86. Harding H. P., Zhang Y., Ron D. 1999. Protein translation and folding are coupled by an endoplasmicreticulum-resident kinase. Nature. 397, 271-274.
87. Shi Y., Vattem K. M., Sood R., An J., Liang J., Stramm L., Wek R. C. 1998. Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol. Cell Biol. 18, 7499-7509.
88. Bertolotti A., Zhang Y., Hendershot L. M., Harding H. P., Ron D. 2000. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nature Cell Biol. 2, 326-332.
89. Okada T., Yoshida H., Akazawa R., Negishi M., Mori K. 2002. Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. Biochem. J. 366, 585-594.
90. Harding H. P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., Ron D. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell. 6, 1099-1108.
91. Vattem K. M., Wek R. C. 2004. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 101, 11269-11274.
92. Cullinan S. B., Diehl J. A. 2004. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem. 279, 20108-20117.
93. Ma Y., Brewer J. W., Diehl J. A., Hendershot L. M. 2002. Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J. Mol. Biol. 318, 1351-1365.
94. Hong M., Luo S., Baumeister P., Huang J. M., Gogia R. K., Li M., Lee A. S. 2004. Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response. J. Biol. Chem. 279, 11354-11363.
95. Yoshida H., Okada T., Haze K., Yanagi H., Yura T., Negishi M., Mori K. 2000. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell Biol. 20, 6755-6767.
96. Yoshida H., Matsui T., Yamamoto A., Okada T., Mori K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 107, 881-891.
97. Ye J., Rawson R. B., Komuro R., Chen X., Dave U. P., Prywes R., Brown M. S., Goldstein J. L. 2000. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell. 6, 1355-1364.
98. Yoshida H., Haze K., Yanagi H., Yura T., Mori K. 1998. Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J. Biol. Chem. 273, 33741-33749.
99. Kokame K., Kato H., Miyata T. 2001. Identification of ERSE-II, a new cis-acting element responsible for the ATF6-dependent mammalian unfolded protein response. J. Biol. Chem. 276, 9199-9205.
100. Kohno K. 2007. How transmembrane proteins sense endoplasmic reticulum stress. Antioxid. Redox Signal. 9, 2295-2303.
101. Liu C. Y., Schroder M., Kaufman R. J. 2000. Ligandindependent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem. 275, 24881-24885.
102. Credle J. J., Finer-Moore J. S., Papa F. R., Stroud R. M., Walter P. 2005. On the mechanism of sensing unfolded protein in the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 102, 18773-18784.
103. Calfon M., Zeng H., Urano F., Till J. H., Hubbard S. R., Harding H. P., Clark S. G., Ron D. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 415, 92-96.
104. Lee K., Tirasophon W., Shen X., Michalak M., Prywes R., Okada T., Yoshida H., Mori K., Kaufman R. J. 2002. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16, 452-466.
105. Yamamoto K., Yoshida H., Kokame K., Kaufman R. J., Mori K. 2004. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J. Biochem. 136, 343-350.
106. Lee A. H., Iwakoshi N. N., Glimcher L. H. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell Biol. 23, 7448-7459.
107. Ng D. T., Spear E. D., Walter P. 2000. The unfolded protein response regulates multiple aspects of secretory and membrane protein biogenesis and endoplasmic reticulum quality control. J. Cell Biol. 150, 77-88.
108. Yoshida H., Matsui T., Hosokawa N., Kaufman R. J., Nagata K., Mori K. 2003. A time-dependent phase shift in the mammalian unfolded protein response. Dev. Cell. 4, 265-271.
109. Yan W., Frank C. L., Korth M. J., Sopher B. L., Novoa I., Ron D., Katze M. G. 2002. Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK. Proc. Natl. Acad. Sci. U. S. A. 99, 15920-15925.
110. Asselah T., Bieche I., Mansouri A., Laurendeau I., Cazals-Hatem D., Feldmann G., Bedossa P., Paradis V., Martinot-Peignoux M., Lebrec D., Guichard C., Ogier-Denis E., Vidaud M., Tellier Z., Soumelis V., Marcellin P., Moreau R. 2010. In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. J. Pathol. 221, 264-274.
111. Gale M. J., Jr., Korth M. J., Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 230, 217-227.
112. Taylor D. R., Shi S. T., Romano P. R., Barber G. N., Lai M. M. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science. 285, 107-110.
113. Pavio N., Romano P. R., Graczyk T. M., Feinstone S. M., Taylor D. R. 2003. Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2-alpha kinase PERK. J. Virol. 77, 3578-3585.
114. Tardif K. D., Mori K., Kaufman R. J., Siddiqui A. 2004. Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J. Biol. Chem. 279, 17158-17164.
115. Kaufman R. J. 1999. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev. 13, 1211-1233.
116. Tardif K. D., Siddiqui A. 2003. Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic repliconexpressing cells. J. Virol. 77, 11644-11650.
117. Reimold A. M., Etkin A., Clauss I., Perkins A., Friend D. S., Zhang J., Horton H. F., Scott A., Orkin S. H., Byrne M. C., Grusby M. J., Glimcher L. H. 2000. An essential role in liver development for transcription factor XBP-1. Genes Dev. 14, 152-157.
118. Kishimoto T., Kokura K., Ohkawa N., Makino Y., Yoshida M., Hirohashi S., Niwa S., Muramatsu M., Tamura T. 1998. Enhanced expression of a new class of liver-enriched b-Zip transcription factors, hepatocarcinogenesis-related transcription factor, in hepatocellular carcinomas of rats and humans. Cell Growth Diff. 9, 337-344.
119. Shuda M., Kondoh N., Imazeki N., Tanaka K., Okada T., Mori K., Hada A., Arai M., Wakatsuki T., Matsubara O., Yamamoto N., Yamamoto M. 2003. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J. Hepatol. 38, 605-614.
120. Dionisio N., Garcia-Mediavilla M. V., Sanchez-Campos S., Majano P. L., Benedicto I., Rosado J. A., Salido G. M., Gonzalez-Gallego J. 2009. Hepatitis C virus NS5A and core proteins induce oxidative stressmediated calcium signalling alterations in hepatocytes. J. Hepatol. 50, 872-882.
121. Korenaga M., Okuda M., Otani K., Wang T., Li Y., Weinman S. A. 2005. Mitochondrial dysfunction in hepatitis C. J. Clin. Gastroenterol. 39, S162-S166.
122. Okuda M., Li K., Beard M. R., Showalter L. A., Scholle F., Lemon S. M., Weinman S. A. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 122, 366-375.
123. de Mochel N. S., Seronello S., Wang S. H., Ito C., Zheng J. X., Liang T. J., Lambeth J. D., Choi J. 2010. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology. 52, 47-59.
124. Boudreau H. E., Emerson S. U., Korzeniowska A., Jendrysik M. A., Leto T. L. 2009. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: A new contributor to HCV-induced oxidative stress. J. Virol. 83, 12934-12946.
125. Santos C. X., Tanaka L. Y., Wosniak J. J., Laurindo F. R. 2009. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: Roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport and nadph oxidase. Antioxid. Redox Signal. 11, 2409-2427.
126. Mahmood S., Kawanaka M., Kamei A., Izumi A., Nakata K., Niiyama G., Ikeda H., Hanano S., Suehiro M., Togawa K., Yamada G. 2004. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid. Redox Signal. 6, 19-24.
127. Mitsuyoshi H., Itoh Y., Sumida Y., Minami M., Yasui K., Nakashima T., Okanoue T. 2008. Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C. Hepatol. Res. 38, 348-353.
128. Di Bona D., Cippitelli M., Fionda C., Camma C., Licata A., Santoni A., Craxi A. 2006. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J. Hepatol. 45, 271-279.
129. Nishina S., Hino K., Korenaga M., Vecchi C., Pietrangelo A., Mizukami Y., Furutani T., Sakai A., Okuda M., Hidaka I., Okita K., Sakaida I. 2008. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology. 134, 226-238.
130. Fujita N., Horiike S., Sugimoto R., Tanaka H., Iwasa M., Kobayashi Y., Hasegawa K., Ma N., Kawanishi S., Adachi Y., Kaito M. 2007. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic. Biol. Med. 42, 353-362.
131. Waris G., Siddiqui A. 2005. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: Role of prostaglandin E2 in RNA replication. J. Virol. 79, 9725-9734.
132. Okamoto T., Sanda T., Asamitsu K. 2007. NF-kappa B signaling and carcinogenesis. Curr. Pharm. Des. 13, 447-462.
133. Bowman T., Garcia R., Turkson J., Jove R. 2000. STATs in oncogenesis. Oncogene. 19, 2474-2488.
134. Waris G., Livolsi A., Imbert V., Peyron J. F., Siddiqui A. 2003. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J. Biol. Chem. 278, 40778-40787.
135. Burdette D., Olivarez M., Waris G. 2010. Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J. Gen. Virol. 91, 681-690.
136. Levent G., Ali A., Ahmet A., Polat E. C., Aytac C., Ayse E., Ahmet S. 2006. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J. Transl. Med. 4, 25. doi: 10. 1186/1479-5876-4-25.
137. Swietek K., Juszczyk J. 1997. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J. Viral Hepat. 4, 139-141.
138. Barbaro G., Di Lorenzo G., Soldini M., Parrotto S., Bellomo G., Belloni G., Grisorio B., Barbarini G. 1996. Hepatic glutathione deficiency in chronic hepatitis C: Quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am. J. Gastroenterol. 91, 2569-2573.
139. Hinoshita E., Taguchi K., Inokuchi A., Uchiumi T., Kinukawa N., Shimada M., Tsuneyoshi M., Sugimachi K., Kuwano M. 2001. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J. Hepatol. 35, 765-773.